Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone treatment of adult women with Turner syndrome: body composition and cardiac function
2005-005510-21Phase 4Completed
- Sponsor
- Department of Endocrinology and Internal Medicine
- Start
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatropin in Turner syndrome (TS), cardiac morbidity, type 2 diabetes mellitus (T2DM) and 2 more, sponsored by Department of Endocrinology and Internal Medicine. Primary endpoints: Cardiovascular parameters by cardiac PET and Body composition. Started Feb 2006; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)cardiac morbiditytype 2 diabetes mellitus (T2DM)aortic aneurysmhypertension (HTN)
Beyond the preview
Go deeper on 2005-005510-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005510-21.